Literature DB >> 6363566

Deposition of the membrane attack complex of complement in bullous pemphigoid.

M V Dahl, R J Falk, R Carpenter, A F Michael.   

Abstract

Bullous pemphigoid is associated with deposition of IgG and C3 at the dermal-epidermal junction. In order to see whether complement activation in bullous pemphigoid resulted in deposition of membrane attack complex (MAC) at the basement membrane zone, skin biopsies from patients with bullous pemphigoid were examined using a direct immunofluorescence technique. By employing a monoclonal antibody to a neoantigen of C9, the MAC was demonstrated in linear pattern at the basement membrane zone. These deposits were seen in both involved and uninvolved skin but the amount of MAC was greater in involved skin as judged by intensity of staining. Stippled deposits of MAC were also present in or around epidermal basal cells. The MAC could be generated in vitro by reaction of normal plasma with antibasement membrane antibody bound to sections of monkey esophagus. The IgG antibody activated complement and this complement activation proceeded all the way to the terminal step.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363566     DOI: 10.1111/1523-1747.ep12259679

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

Authors:  E Schmidt; B Bastian; R Dummer; H P Tony; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

2.  Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.

Authors:  L Borrego; B Maynard; E A Peterson; T George; L Iglesias; M S Peters; W Newman; G J Gleich; K M Leiferman
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 3.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

4.  Characterization of homologous restriction factor (HRF20) in human skin and leucocytes.

Authors:  K Sayama; S Shiraishi; Y Shirakata; Y Kobayashi; N Okada; H Okada; Y Miki
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 5.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

6.  Role of different pathways of the complement cascade in experimental bullous pemphigoid.

Authors:  Kelly C Nelson; Minglang Zhao; Pamela R Schroeder; Ning Li; Rick A Wetsel; Luis A Diaz; Zhi Liu
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

7.  Membrane attack complex of complement in Henoch-Schönlein purpura skin and nephritis.

Authors:  S Kawana; G H Shen; Y Kobayashi; S Nishiyama
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

8.  Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

Authors:  F Niculescu; F Hugo; H G Rus; R Vlaicu; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

9.  Bullous pemphigoid autoantibodies reactive with intracellular basal keratinocyte antigens: studies of subclass distribution and complement activation.

Authors:  R E Jordon; P Xia; W D Geoghegan
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

10.  Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy.

Authors:  A V Cybulsky; H G Rennke; I D Feintzeig; D J Salant
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.